Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold

Silk Road Medical stock has undergone multiple analysts rating changes in the recent past.  Silk Road Medical Downgraded by Zacks Investment Research on 10/30/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of Silk Road Medical traded down -$1.93 on Friday, reaching $58.71. 219114 shares of the stock traded hands, compared to its average volume of 218917. Shares of Silk Road Medical were trading at $58.71 on Friday. The firm’s 50 day moving average is $57.35 and its 200 day moving average is $53.09.Silk Road Medical has a 12 month low of $57.66 and a 12 month high of $75.80. While on yearly highs and lows, Silk Road Medical’s today has traded high as $60.79 and has touched $57.66 on the downward trend. See More Analyst Rating at: RATING

Silk Road Medical Earnings and What to expect: 

Silk Road Medical last announced its earnings results on July 29th, 2021. The reported ($0.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.06. The company earned $26.46 million during the quarter, compared to the consensus estimate of $25.33 million. Silk Road Medical has generated ($1.44) earnings per share over the last year (($1.42) diluted earnings per share). Earnings for Silk Road Medical are expected to grow in the coming year, from ($1.24) to ($0.89) per share. Silk Road Medical has confirmed that its next quarterly earnings report will be published on Tuesday, November 9th, 2021. Silk Road Medical will be holding an earnings conference call on Tuesday, November 9th at 4:30 PM Eastern. Interested parties can .

Earnings for Silk Road Medical are expected to grow in the coming year, from ($1.24) to ($0.89) per share. The P/E ratio of Silk Road Medical is -41.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Silk Road Medical is -41.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Silk Road Medical has a P/B Ratio of 18.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Silk Road Medical (NASDAQ:SILK) Moving Average Technical Analysis

5 day Moving Average is $60.11 And 5 day price change is -$0.58 (-0.98%)  with average volume for 5 day average is 174,800. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $57.19 and 20 day price change is $4.25 (7.80%) and average 20 day moving volume is 211,365. 50 day moving average is $57.35  and 50 day price change is $11.37 ( 24.02%)  and with average volume for 50 days is : 265,026. 200 day moving average is $53.09  and 200 day price change is $0.36 (0.62%)  and with average volume for 200 days is : 318,775.

Other owners latest trading in Silk Road Medical :

  • On 10/29/2021 shares held by Amalgamated Bank were 6,034 which equates to market value of $0.33M and appx 0.00% owners of Silk Road Medical
  • On 10/29/2021 shares held by Commonwealth Equity Services LLC were 6,536 which equates to market value of $0.36M and appx 0.00% owners of Silk Road Medical
  • On 10/28/2021 shares held by M&T Bank Corp were 59,626 which equates to market value of $3.28M and appx 0.00% owners of Silk Road Medical
  • In total Institutional ownership equates to for Silk Road Medical

See More Analyst Rating at: RATING